83 related articles for article (PubMed ID: 28370286)
1. The Generation and Validation of a 20-Genes Model Influencing the Prognosis of Colorectal Cancer.
Xie XJ; Liu P; Cai CD; Zhuang YR; Zhang L; Zhuang HW
J Cell Biochem; 2017 Nov; 118(11):3675-3685. PubMed ID: 28370286
[TBL] [Abstract][Full Text] [Related]
2. Cell cycle related genes up-regulated in human colorectal development predict the overall survival of late-stage colorectal cancer patients.
An N; Yang X; Zhang Y; Shi X; Yu X; Cheng S; Zhang K; Wang G
Mol Biosyst; 2016 Feb; 12(2):541-52. PubMed ID: 26672738
[TBL] [Abstract][Full Text] [Related]
3. Identification of key pathways and genes in colorectal cancer using bioinformatics analysis.
Liang B; Li C; Zhao J
Med Oncol; 2016 Oct; 33(10):111. PubMed ID: 27581154
[TBL] [Abstract][Full Text] [Related]
4. CBX8 and CD96 Are Important Prognostic Biomarkers of Colorectal Cancer.
Song X; Tang T; Li C; Liu X; Zhou L
Med Sci Monit; 2018 Nov; 24():7820-7827. PubMed ID: 30383736
[TBL] [Abstract][Full Text] [Related]
5. Gene expression analysis of colorectal cancer by bioinformatics strategy.
Cui M; Yuan J; Li J; Sun B; Li T; Li Y; Wu G
Hepatogastroenterology; 2014 Oct; 61(135):1942-5. PubMed ID: 25713892
[TBL] [Abstract][Full Text] [Related]
6. Prediction of novel target genes and pathways involved in bevacizumab-resistant colorectal cancer.
Makondi PT; Lee CH; Huang CY; Chu CM; Chang YJ; Wei PL
PLoS One; 2018; 13(1):e0189582. PubMed ID: 29342159
[TBL] [Abstract][Full Text] [Related]
7. Identification of key genes in colorectal cancer using random walk with restart.
Cui X; Shen K; Xie Z; Liu T; Zhang H
Mol Med Rep; 2017 Feb; 15(2):867-872. PubMed ID: 28000901
[TBL] [Abstract][Full Text] [Related]
8. A prognostic 11 genes expression model for ovarian cancer.
Men CD; Liu QN; Ren Q
J Cell Biochem; 2018 Feb; 119(2):1971-1978. PubMed ID: 28817186
[TBL] [Abstract][Full Text] [Related]
9. Screening and regulatory network analysis of survival-related genes of patients with colorectal cancer.
Qi L; Ding Y
Sci China Life Sci; 2014 May; 57(5):526-31. PubMed ID: 24722856
[TBL] [Abstract][Full Text] [Related]
10. Genetic and Immunohistochemical Expression of Integrins ITGAV, ITGA6, and ITGA3 As Prognostic Factor for Colorectal Cancer: Models for Global and Disease-Free Survival.
Linhares MM; Affonso RJ; Viana Lde S; Silva SR; Denadai MV; de Toledo SR; Matos D
PLoS One; 2015; 10(12):e0144333. PubMed ID: 26674523
[TBL] [Abstract][Full Text] [Related]
11. Discovery of a Novel Immune Gene Signature with Profound Prognostic Value in Colorectal Cancer: A Model of Cooperativity Disorientation Created in the Process from Development to Cancer.
An N; Shi X; Zhang Y; Lv N; Feng L; Di X; Han N; Wang G; Cheng S; Zhang K
PLoS One; 2015; 10(9):e0137171. PubMed ID: 26325386
[TBL] [Abstract][Full Text] [Related]
12. Identification of a prognostic 5-Gene expression signature for gastric cancer.
Hou JY; Wang YG; Ma SJ; Yang BY; Li QP
J Cancer Res Clin Oncol; 2017 Apr; 143(4):619-629. PubMed ID: 28035468
[TBL] [Abstract][Full Text] [Related]
13. A prognostic 4-gene expression signature for squamous cell lung carcinoma.
Li J; Wang J; Chen Y; Yang L; Chen S
J Cell Physiol; 2017 Dec; 232(12):3702-3713. PubMed ID: 28160492
[TBL] [Abstract][Full Text] [Related]
14. ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis.
Agesen TH; Sveen A; Merok MA; Lind GE; Nesbakken A; Skotheim RI; Lothe RA
Gut; 2012 Nov; 61(11):1560-7. PubMed ID: 22213796
[TBL] [Abstract][Full Text] [Related]
15. Identification of hub genes, key miRNAs and potential molecular mechanisms of colorectal cancer.
Wu S; Wu F; Jiang Z
Oncol Rep; 2017 Oct; 38(4):2043-2050. PubMed ID: 28902367
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of NOX4 predicts poor prognosis and promotes tumor progression in human colorectal cancer.
Lin XL; Yang L; Fu SW; Lin WF; Gao YJ; Chen HY; Ge ZZ
Oncotarget; 2017 May; 8(20):33586-33600. PubMed ID: 28422720
[TBL] [Abstract][Full Text] [Related]
17. Identification of miRNA-miRNA synergistic relationships in colorectal cancer.
Zhao X; Song H; Zuo Z; Zhu Y; Dong X; Lu X
Int J Biol Macromol; 2013 Apr; 55():98-103. PubMed ID: 23246904
[TBL] [Abstract][Full Text] [Related]
18. Validation of biomarkers associated with 5-fluorouracil and thymidylate synthase in colorectal cancer.
Xi Y; Formentini A; Nakajima G; Kornmann M; Ju J
Oncol Rep; 2008 Jan; 19(1):257-62. PubMed ID: 18097604
[TBL] [Abstract][Full Text] [Related]
19. A network-based predictive gene-expression signature for adjuvant chemotherapy benefit in stage II colorectal cancer.
Cao B; Luo L; Feng L; Ma S; Chen T; Ren Y; Zha X; Cheng S; Zhang K; Chen C
BMC Cancer; 2017 Dec; 17(1):844. PubMed ID: 29237416
[TBL] [Abstract][Full Text] [Related]
20. Gene expression profiling-derived immunohistochemistry signature with high prognostic value in colorectal carcinoma.
Chang W; Gao X; Han Y; Du Y; Liu Q; Wang L; Tan X; Zhang Q; Liu Y; Zhu Y; Yu Y; Fan X; Zhang H; Zhou W; Wang J; Fu C; Cao G
Gut; 2014 Sep; 63(9):1457-67. PubMed ID: 24173294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
